In the Belly Fat study, the effects of two different caloric-restricted diets on metabolic health will be examined in male and female subjects with increased abdominal adiposity (BMI \>27 kg/m2). Metabolic health is defined as health of the primary metabolic organs the liver, gut and the adipose tissue, examined in a static state as well as after the application of a challenge test. The diets are equally caloric-restricted, but differ in nutrient composition. It is hypothesized that one of the two diets causes a larger improvement in organ health and reduction in liver fat.
Rationale: It is known that in particular visceral fat (abdominal obesity) and fat deposition in non-adipose tissue such as the liver are important factors related to metabolic health, such as the degree of insulin resistance, dyslipidaemia and other well-established cardio-metabolic risk factors. The arise of pathological consequences of abdominal obesity are a result of a disturbance in the elegant interplay between metabolic organs, such as the liver, adipose tissue and gut. Several nutrients have demonstrated to exert positive or negative effects on the health and functioning of metabolic organs. A diet (whole dietary approach) can thus be a power tool to improve the health status of individuals with abdominal obesity by improving organ health. Objective: The primary objective of this study is to compare the effects of two different diets on the static metabolic health status as assessed by determination of organ health and, more specifically, of lipid accumulation in the liver. The application of a mixed meal challenge test will be used to gain insight in the dynamic metabolic health status. A secondary objective is to determine the reaction (brain activity) of individuals with abdominal obesity after visual and olfactory food-cues. Study design and intervention: Randomized, parallel design consisting of three groups: 1. 40 subjects, 12-wk nutritional intervention based on dietary advice: diet with 30% caloric restriction and a Western style nutrient composition 2. 40 subjects, 12-wk nutritional intervention based on dietary advice: diet with 30% caloric restriction with a nutrient composition aimed at improving organ health and reducing liver fat 3. 30 subjects, control group, no nutritional intervention (optional: dietary advice at the end of the study period) Measurements on metabolic health will be conducted at baseline and after 12-wk intervention and include: * MR imaging for determining body fat distribution * MR spectroscopy for quantification of liver fat * Blood sampling (plasma and PBMCs) before and several timepoints after mixed meal challenge * Adipose tissue sampling before and after mixed meal challenge * Vascular measurements before and after mixed meal challenge * Urine and feces sampling Study population: Males and females, 40-70 yrs old, BMI \> 27 kg/m2
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
110
Dietary advice, guided by professional dieticians. Caloric restricted (-30en%) diet with Western type nutrient composition (SFA, carbohydrates, sugars, fruit juice, meat, dairy)
Dietary advice, guided by professional dieticians. Caloric restricted (-30en%) diet with nutrient composition aiming at an improvement in organ health and a reduction in liver fat (PUFA, fish, soy protein, whole grain)
Intrahepatic lipid accumulation (IHL)
Assessment of IHL by means of 1H-MRS (magnetic resonance spectroscopy)
Time frame: Baseline and after 12-wk intervention
Body fat distribution
Assessment of body fat distribution (SAT/VAT) by means of MRI (magnetic resonance imaging)
Time frame: Baseline and after 12-wk intervention
Adipose tissue gene expression before and 4h after a mixed meal challenge
Micro-array/qPCR
Time frame: Baseline and after 12-wk intervention
Markers of liver health (plasma) before and after mixed meal challenge
Liver enzymes
Time frame: Baseline and after 12-wk intervention
Cardio-metabolic risk factors (plasma) before and after mixed meal challenge
Insulin, glucose, Tg
Time frame: Baseline and after 12-wk intervention
Inflammatory markers (plasma) before and after mixed meal challenge
Cytokines
Time frame: Baseline and after 12-wk intervention
Markers of adipose tissue health (plasma)
Adipokines
Time frame: Baseline and after 12-wk intervention
Markers of gut health (plasma)
Gut hormones
Time frame: Baseline and after 12-wk intervention
Microbiota (faeces)
Time frame: Baseline and after 12-wk intervention
Urinary metabolites
Time frame: Baseline and after 12-wk intervention
PBMC gene expression profile
Micro-array/qPCR
Time frame: Baseline and after 12-wk intervention
Vascular functions (blood pressure and arterial stiffness) before and after mixed meal challenge
PWA
Time frame: Baseline and after 12-wk intervention
Satiety and wellbeing before and after mixed meal challenge
Assessment by validated questionnaires
Time frame: Baseline and after 12-wk intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.